CFO Studio Advisory Board and Technical Review Committee
| Tim Anglim Timothy (Tim) Anglim, founder and president of YesCFO, is an accomplished chief financial officer who is widely recognized for his crisis management expertise. With over 25 years experience leading accounting and financial functions, he has played a key role in numerous turnarounds and reorganizations, as well as the rapid expansion, of numerous companies. He has personally led strategy and negotiations for debt restructuring, addressed severe cash liquidity situations, and resolved issues concerning the misstatement of financial statements. Tim is also highly regarded for his effective leadership and human resource skills. “Profits are an opinion. Cash is a fact.” | |
| Michael Eldredge American Sensor Technologies Chief Financial Officer Michael Eldredge is one of the founding partners of American Sensor Technologies, Inc., a high-technology sensor developer and manufacturer where he is its Executive Vice President – COO / CFO and Chairman. Prior to the start of American Sensor Technologies Michael held various managerial and executive positions with such noted companies and American Cyanamid, Johnson and Johnson and later with Biosearch Medical Products and Measurement Specialties.With a broad background in finance and administration, Michael leverages his talents and gained experiences in one of the most successful sensor companies formed in the past 12 years. He was awarded CFO of the Year in 2006 by the New Jersey Technology Council, Entrepreneur of the Year in 2007 by Ernst and Young and has been a finalist in the 2011 and 2012 NJBIZ CFO of the Year programs. Michael’s believes that his professional standards have been key to his success. “When others say you will not succeed – prove them wrong. Always be proactive in your responsibilities and never take the attitude that something isn’t your job. Never put yourself above your staff, but rather mentor others and always be open to being mentored. Always be truthful and maintain the highest level of integrity. Keep in mind that greed always precedes failure.” | |
| Bert Marchio Edge Therapeutics Chief Accouninting & Operations Officer Mr. Marchio brings 25 years of experience in senior financial leadership positions in both the public and private sectors, with the last 19 years spent in the pharmaceutical industry, currently serving as the Chief Financial Officer for Edge Therapeutics, an early stage, hospital-focused biopharmaceutical company. Previously, he was the Executive Vice President, Chief Financial Officer of Informed Medical Communications. Prior to that, he served as Vice President, Treasurer of MedPointe where he helped lead the financial turnaround and eventual sale of the company. Mr. Marchio is also a Managing Operating Partner with Three Fields Capital, a multi-strategy investment firm focused exclusively on healthcare related companies. Mr. Marchio holds a BA in Economics from Muhlenberg College, an MBA in Professional Accounting from Rutgers Graduate School of Business and a Post-MBA Certificate in Taxation from Bernard Baruch College of the City University of New York.“We need to tax employer provided healthcare if we want people to start making logical healthcare buying decisions; all compensation should be treated equally.” | |
 | Howard Reba Marlin Equity Partners Finance Director Howard Reba has over 20 years of finance experience helping companies achieve their goals. His specialties include driving financial performance improvement, leading organizational transformation, and piloting M&A assignments. Howard has concentrated his energy on service organizations, particularly financial services, technology services, and professional services. In recent years, Howard has tackled entrepreneurial and growth issues at organizations focused on providing technology services. Currently, he serves as CFO at Fidelus Technologies, a leading provider of unified communication and collaboration services. Previously, Howard was CFO at cloud services provider External IT. In these roles he has upgraded the finance organizations and driven strategic decision-making through business case development.
| |
 | Andrew Savadelis Angion Biomedica Chief Financial OfficerMr. Savadelis is an accomplished finance expert with years of experience leading strategy for commercialization stage companies in the technology and biotech industries. Having served in the COO capacity in both public and private organizations, he brings demonstrated success in finance, operations, M&A, strategic alliance negotiations, has raised debt and equity financings, and has handled private, public and IPO financings in both growth and turnaround companies. Mr. Savadelis has served as COO in several companies, on the audit committee and as a Board member of a public biotech company. In his past role as CFO of AE Polysilicon Corporation, he most recently worked with the Department of Energy to negotiate a $250M loan guarantee, and was responsible for the executing market capitalization by 600% to over $130M for a biotech company. He previously managed a $2.4B cash portfolio and worldwide cash flows for Bristol-Myers Squibb. Mr. Savadelis earned his B.S. in biology from Albright College and his M.B.A from Cornell University. |
